FIGURE 3.
Kaplan‐Meier curves of progression‐free survival in patients treated with crizotinib or platinum‐pemetrexed chemotherapy as first‐line treatment. CI, confidence interval; PFS, progression‐free survival
Kaplan‐Meier curves of progression‐free survival in patients treated with crizotinib or platinum‐pemetrexed chemotherapy as first‐line treatment. CI, confidence interval; PFS, progression‐free survival